We unleash your business potential by maximize the business innovation.
Send EmailValine, L-Valine, L(+)-alpha-Aminoisovaleric Acid, BCAA, 72-18-4
L-Valine / Valine / (S)-2-Amino-3-methylbutanoic acid / BCAA
CAS Number: 72-18-4
EC Number: 200-773-6
| Parameter | Description |
|---|---|
| Chemical Name (IUPAC) | (S)-2-Amino-3-methylbutanoic acid |
| Other Names | L-Valine, Valine, 2-Amino-3-methylbutanoic acid, L-alpha-Amino-beta-methylbutyric acid, L(+)-alpha-Aminoisovaleric Acid |
| CAS Number | 72-18-4 |
| EC Number (EINECS) | 200-773-6 |
| Molecular Formula | C₅H₁₁NO₂ |
| Molecular Weight | 117.15 g/mol |
| Chemical Class | Amino acid (branched-chain amino acid - BCAA) |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Taste | Slightly sweet to bitter |
L-Valine is an essential amino acid belonging to the branched-chain amino acid (BCAA) family, along with L-leucine and L-isoleucine. It is one of the nine essential amino acids that cannot be synthesized by the human body and must be obtained through diet or supplementation. L-Valine has a hydrophobic, aliphatic side chain and is a critical component of protein synthesis. It plays a vital role in muscle growth, tissue repair, nitrogen balance regulation, and nervous system function. The compound was first isolated from the valerian plant (Valeriana officinalis), from which it derives its name. L-Valine appears as a white, odorless, crystalline powder with a slightly sweet to bitter taste. It is soluble in water (88.5 g/L at 25°C) but insoluble in ethanol and ether. L-Valine is widely used in sports nutrition, dietary supplements, medical applications, functional foods, and child nutrition products.
| Property | Value |
|---|---|
| Molecular Formula | C₅H₁₁NO₂ |
| Molecular Weight | 117.15 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Taste | Slightly sweet to bitter |
| Density (25°C) | 1.23 g/cm³ |
| Melting Point | ~315°C (sublimes) |
| Boiling Point | ~298°C (decomposes upon heating) |
| Water Solubility (25°C) | 88.5 g/L (increases with temperature) |
| Solubility in Ethanol | Insoluble |
| Solubility in Ether | Insoluble |
| pH (1% solution) | ~5.5-6.5 |
| Specific Optical Rotation ([α]²⁰D) | +27.0 to +29.0° (c=8, 6N HCl) |
| pKa (25°C) | 2.32 (COOH), 9.62 (α-NH₂) |
| Isoelectric Point | 5.96 |
| Nitrogen Content | ~11.9% (by weight) |
| Enantiomeric Purity | ≥ 98.0% (L-form, typically ≥ 99%) |
| Loss on Drying | ≤ 0.3% |
| Residue on Ignition | ≤ 0.1% |
| Heavy Metals | ≤ 10 ppm (as Pb) |
| Chloride Content | ≤ 0.05% |
| Sulfate Content | ≤ 0.05% |
L-Valine is a white, odorless, crystalline powder with a slightly sweet to bitter taste. Its density is 1.23 g/cm³ at 25°C. The melting point is approximately 315°C, at which it sublimes, and the boiling point is approximately 298°C, at which it decomposes upon heating. It is soluble in water (88.5 g/L at 25°C) with solubility increasing at higher temperatures, but it is insoluble in ethanol and ether. The specific optical rotation is +27.0 to +29.0° (c=8, 6N HCl), confirming the L-configuration. The pKa values are 2.32 (carboxyl group) and 9.62 (amino group), with an isoelectric point of 5.96. The nitrogen content is approximately 11.9% by weight. Typical enantiomeric purity is ≥ 98.0% L-form (often ≥ 99%). Loss on drying is ≤ 0.3%, and residue on ignition is ≤ 0.1%. Heavy metals are typically ≤ 10 ppm (as Pb). Chloride and sulfate contents are each ≤ 0.05%.
L-Valine is a branched-chain amino acid (BCAA) with a hydrophobic, aliphatic side chain. Its chemical behavior is determined by its amino acid functional groups and the branched isopropyl side chain.
Acid-Base Properties:
L-Valine has both carboxyl (COOH) and amino (NH₂) groups. In aqueous solution, it has the following ionization equilibria:
pKa₁ (COOH): 2.32 (carboxyl group deprotonation)
pKa₂ (α-NH₂): 9.62 (amino group deprotonation)
Isoelectric Point: 5.96
Esterification:
L-Valine can be esterified with alcohols to form valine esters, which are used in pharmaceutical intermediates:
C₅H₁₁NO₂ + ROH → C₅H₁₁NO₂·OR + H₂O
Acylation:
The amino group of L-valine can be acylated to form N-acyl derivatives, which are used in peptide synthesis and pharmaceutical applications:
C₅H₁₁NO₂ + RCOCl → C₅H₁₁NO₂·NHCOR + HCl
Transamination:
L-Valine participates in transamination reactions, where its amino group is transferred to α-ketoglutarate to form glutamate and α-ketoisovalerate.
Decarboxylation:
L-Valine can be decarboxylated by the enzyme valine decarboxylase to form isobutylamine.
Maillard Reaction:
Like other amino acids, L-valine can participate in Maillard reactions with reducing sugars, forming brown pigments and flavor compounds.
Thermal Decomposition:
At temperatures above 315°C, L-valine decomposes to produce volatile compounds including ammonia, carbon dioxide, and various nitrogen-containing compounds.
L-Valine is produced industrially primarily through fermentation processes using microorganisms that have been developed to overproduce L-valine.
| Method | Raw Materials | Process Description |
|---|---|---|
| Fermentation (Microbial) | Glucose, Sucrose, Ammonia, Mineral salts | Microorganisms such as Corynebacterium glutamicum or Escherichia coli are cultivated in fermenters. The organisms produce L-valine, which is secreted into the fermentation broth. The broth is then processed to isolate and purify L-valine. This is the most common industrial method. |
| Chemical Synthesis | α-Chloroisovaleric acid, Ammonia | α-Chloroisovaleric acid is reacted with ammonia to produce DL-valine, which is then resolved to obtain L-valine. This method is less common than fermentation. |
| Enzymatic Synthesis | α-Ketoisovaleric acid, Ammonia, NADH | α-Ketoisovaleric acid is enzymatically converted to L-valine using valine dehydrogenase or similar enzymes. This method provides high purity and yield but requires specialized enzymes. |
Detailed Production Process (Fermentation Method - Most Common):
Microorganism Cultivation: Genetically modified strains of Corynebacterium glutamicum or Escherichia coli that overproduce L-valine are cultivated in fermentation vessels containing glucose or sucrose as the carbon source, ammonia as the nitrogen source, and various mineral salts.
Fermentation: The microorganisms are grown under controlled conditions (temperature, pH, aeration, agitation) for 40-60 hours. During this time, the microorganisms convert the carbon source to L-valine, which is secreted into the fermentation broth.
Harvesting: The fermentation broth is harvested, and the microorganisms are removed by filtration or centrifugation.
Purification: The L-valine is purified from the broth using a series of steps, including ion exchange chromatography, activated carbon treatment, and crystallization.
Crystallization: The purified L-valine is crystallized from the solution, isolated by filtration, and washed.
Drying: The crystals are dried to reduce the moisture content to ≤ 0.3%.
Milling and Packaging: The dried crystals are milled to the desired particle size and packaged in appropriate containers.
L-Valine is an essential branched-chain amino acid (BCAA) that plays numerous critical roles in the body. It is involved in protein synthesis, muscle growth and repair, nitrogen balance regulation, and nervous system function.
| Benefit | Description |
|---|---|
| Protein Synthesis | Essential amino acid for protein synthesis; required for the formation of all proteins in the body. |
| Muscle Growth | Promotes muscle growth and development, especially when combined with leucine and isoleucine. |
| Tissue Repair | Supports tissue repair and wound healing. |
| Nitrogen Balance | Regulates nitrogen balance in the body, supporting positive nitrogen balance for muscle building. |
L-Valine is one of the essential amino acids required for protein synthesis. It is incorporated into proteins during translation and is necessary for the formation of all proteins in the body. Along with leucine and isoleucine, L-valine plays a critical role in muscle protein synthesis, promoting muscle growth and development.
| Benefit | Description |
|---|---|
| Athletic Performance | Supports athletic performance by promoting muscle protein synthesis and reducing muscle breakdown. |
| Recovery | Accelerates post-exercise recovery by reducing muscle damage and promoting repair. |
| Endurance | May improve endurance by reducing central fatigue during prolonged exercise. |
| Muscle Soreness | May help reduce exercise-induced muscle soreness (DOMS). |
L-Valine, as part of the BCAA group, is widely used in sports nutrition. It helps reduce muscle breakdown during exercise, supports protein synthesis, and accelerates post-exercise recovery. It may also help reduce exercise-induced muscle soreness and improve endurance.
| Benefit | Description |
|---|---|
| Neurotransmitter Precursor | Acts as a precursor to neurotransmitters and supports nervous system function. |
| Mental Clarity | May support mental clarity and cognitive function. |
| Stress Reduction | May help reduce stress factors and support mood balance. |
| Central Nervous System | Supports central nervous system function and may help in certain neurological conditions. |
L-Valine plays a role in nervous system function. It is involved in the synthesis of neurotransmitters and may support mental clarity, cognitive function, and stress reduction. It has been studied for its potential benefits in central nervous system disorders.
| Benefit | Description |
|---|---|
| Liver Health | Supports liver function and may help in the treatment of liver failure. |
| Ammonia Detoxification | Helps in ammonia detoxification through the urea cycle. |
| Metabolic Disorders | Used in the treatment of certain metabolic disorders. |
| Blood Sugar Regulation | May help regulate blood sugar levels by supporting gluconeogenesis. |
L-Valine supports liver function and has been used in the treatment of liver failure and certain metabolic disorders. It plays a role in ammonia detoxification through the urea cycle.
| Benefit | Description |
|---|---|
| Immune System | Supports immune system function. |
| Wound Healing | Supports wound healing and tissue repair. |
| Growth and Development | Essential for growth and development in children and adolescents. |
| Appetite Regulation | May help regulate appetite and support weight management. |
L-Valine has a wide range of applications in human nutrition, animal nutrition, pharmaceuticals, and the food industry.
| Application | Description |
|---|---|
| BCAA Supplements | Used in BCAA (branched-chain amino acid) blends with leucine and isoleucine for muscle growth and recovery. |
| Protein Powders | Used in protein powders and amino acid blends to enhance the amino acid profile. |
| Pre-Workout Supplements | Used in pre-workout formulations to reduce muscle breakdown during exercise. |
| Post-Workout Supplements | Used in post-workout formulations to accelerate recovery and muscle repair. |
| Endurance Products | Used in endurance products to reduce central fatigue and improve performance. |
| Weight Management | Used in weight management products to preserve lean muscle mass during calorie restriction. |
L-Valine is most commonly used in sports nutrition and dietary supplements. It is a key component of BCAA blends (along with leucine and isoleucine) and is found in protein powders, pre-workout supplements, post-workout supplements, and endurance products. It helps promote muscle growth, accelerate recovery, and reduce muscle breakdown.
| Application | Description |
|---|---|
| Liver Failure Treatment | Used in the treatment of liver failure and hepatic encephalopathy. |
| Metabolic Disorders | Used in the treatment of certain metabolic disorders (e.g., maple syrup urine disease - MSUD). |
| Parenteral Nutrition | Used in amino acid infusion solutions for parenteral nutrition. |
| Neurological Conditions | Used in the treatment of certain central nervous system disorders. |
| Wound Healing | Used in formulations to support wound healing and tissue repair. |
L-Valine is used in medical and pharmaceutical applications for the treatment of liver failure, hepatic encephalopathy, metabolic disorders (such as maple syrup urine disease - MSUD), and certain neurological conditions. It is also used in amino acid infusion solutions for parenteral nutrition.
| Application | Description |
|---|---|
| Functional Foods | Used in functional foods for sports nutrition and health benefits. |
| Protein Bars | Used in protein bars and snacks to improve nutritional profile. |
| Sports Drinks | Used in sports drinks for recovery and performance enhancement. |
| Fortified Foods | Used to fortify foods with essential amino acids. |
| Child Nutrition | Used in child nutrition products to support growth and development. |
L-Valine is used in the food industry to fortify functional foods, protein bars, sports drinks, and child nutrition products. It improves the nutritional profile of these products and provides health benefits.
| Application | Description |
|---|---|
| Animal Feed Supplement | Used as a supplemental amino acid in animal feed (limited use). |
| Poultry Nutrition | Used in poultry feed to support growth and egg production. |
| Aquaculture | Used in aquaculture feed to support growth and health. |
L-Valine is used in animal nutrition as a supplemental amino acid in feed, although its use is limited due to cost considerations. It is used in poultry and aquaculture feed to support growth and production.
| Parameter | Information |
|---|---|
| General Supplementation | 500-1,500 mg per day |
| BCAA Supplementation | 2,000-5,000 mg per day (as part of BCAA blend) |
| Athletic Performance | 1,000-3,000 mg per day (pre- or post-workout) |
| Therapeutic Use | Varies by condition; medical supervision required |
| Timing | Between meals or pre-/post-workout for best absorption |
| Forms | Tablets, capsules, powders, liquids, and ready-to-mix formulations |
| Disclaimer | Dosages may vary based on individual needs and health status. Consult a healthcare professional before use. |
| Side Effect | Description |
|---|---|
| Gastrointestinal Distress | Nausea, diarrhea, abdominal cramps, stomach pain (at high doses) |
| Fatigue | May cause fatigue or drowsiness in some individuals |
| Headache | May cause headache in some individuals |
| Drug Interactions | May interact with levodopa (L-Dopa) and other Parkinson's medications |
| Maple Syrup Urine Disease (MSUD) | Contraindicated in patients with MSUD due to inability to metabolize branched-chain amino acids |
| Kidney/Liver Disease | Use with caution in patients with severe kidney or liver disease |
| Pregnancy and Lactation | Generally safe at recommended doses; consult healthcare professional before use |
| Warning | Side effects are generally mild and occur at high doses. Consult a healthcare professional before use, especially if you have pre-existing conditions or are taking medications. |
| Drug Class | Interaction | Recommendation |
|---|---|---|
| Levodopa (L-Dopa) | May interfere with L-Dopa absorption | Administer L-Dopa 1-2 hours before or after valine |
| Antiparkinsonian Drugs | Possible interactions | Use under medical supervision |
| Hormone Medications | Possible interactions | Use under medical supervision |
| Thyroid Medications | Possible interactions | Use under medical supervision |
| Animal Sources | Plant Sources |
|---|---|
| Meat (beef, lamb, pork) | Soybeans and soy products |
| Poultry (chicken, turkey) | Peanuts |
| Fish (salmon, tuna, cod) | Chickpeas |
| Eggs | Lentils |
| Dairy products (milk, cheese, yogurt) | Beans |
| Seeds (sesame, sunflower) | |
| Nuts (almonds, walnuts) | |
| Whole grains (wheat, oats) | |
| Brown rice |
| Parameter | Value |
|---|---|
| Oral LD50 (Rat) | > 5,000 mg/kg (low toxicity) |
| Dermal LD50 (Rabbit) | > 2,000 mg/kg |
| Skin Irritation | Non-irritant |
| Eye Irritation | Mild irritant |
| Skin Sensitization | Not a sensitizer |
| Mutagenicity | Negative (Ames test) |
| Carcinogenicity | Not classified |
| Reproductive Toxicity | Not classified |
| GRAS Status | Generally Recognized as Safe (GRAS) by FDA |
| Acceptable Daily Intake | Not established (no safety concerns at typical doses) |
| Exposure Route | Action |
|---|---|
| Inhalation | Move person to fresh air. If irritation persists, seek medical attention. |
| Skin Contact | Wash with plenty of soap and water. If irritation persists, seek medical attention. |
| Eye Contact | Rinse immediately with plenty of water for at least 15 minutes. Remove contact lenses if present. If irritation persists, seek medical attention. |
| Ingestion | Rinse mouth with water. Drink plenty of water. Do NOT induce vomiting. Seek medical attention if large amounts are swallowed. |
| Hazard Class | Category |
|---|---|
| Skin Irritation | Category 3 (mild irritation) |
| Eye Irritation | Category 2B (mild irritation) |
| Specific Target Organ Toxicity - Single Exposure | Category 3 (respiratory irritation) |
Signal Word: WARNING
Hazard Statements (H-Codes):
| Code | Statement |
|---|---|
| H315 | Causes skin irritation (mild) |
| H319 | Causes serious eye irritation (mild) |
| H335 | May cause respiratory irritation (dust) |
Precautionary Statements (P-Codes):
| Code | Statement |
|---|---|
| P261 | Avoid breathing dust |
| P271 | Use only outdoors or in a well-ventilated area |
| P280 | Wear protective gloves, protective clothing, eye/face protection |
| P302+P352 | IF ON SKIN: Wash with plenty of soap and water |
| P304+P340 | IF INHALED: Remove person to fresh air and keep comfortable for breathing |
| P305+P351+P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing |
| P332+P313 | If skin irritation occurs: Get medical attention |
| P337+P313 | If eye irritation persists: Get medical attention |
| P403+P233 | Store in a well-ventilated place. Keep container tightly closed |
| P501 | Dispose of contents/container in accordance with local/regional/national/international regulations |
| Parameter | Information |
|---|---|
| Fire Hazard | Combustible dust; dust-air mixtures may be explosive at high concentrations |
| Extinguishing Media | Water spray, CO₂, dry chemical powder, foam |
| Special Hazards | Thermal decomposition produces toxic and irritant fumes (nitrogen oxides, carbon monoxide, carbon dioxide) |
| Protective Equipment | Self-contained breathing apparatus (SCBA), full protective clothing |
| Parameter | Information |
|---|---|
| Personal Protection | Wear appropriate PPE (dust mask, goggles, protective clothing, gloves) |
| Ventilation | Increase ventilation; evacuate area if necessary |
| Containment | Stop source if safe; contain powder to prevent spread |
| Cleaning Methods | Vacuum or sweep carefully to avoid dust generation; use wet methods to suppress dust |
| Environmental Precautions | Prevent entry into drains, sewers, and water bodies |
| Waste Disposal | Dispose of according to local, state, and federal regulations |
| Parameter | Information |
|---|---|
| Storage Conditions | Cool, dry, well-ventilated area; store below 25°C; protect from light and moisture |
| Container Requirements | Tightly closed containers (bags, drums, boxes) |
| Materials to Avoid | Strong oxidizing agents, strong acids, strong bases, moisture |
| Shelf Life | 24-36 months under proper storage conditions |
| Hygroscopicity | Slightly hygroscopic |
| Handling Notes | Avoid dust generation; avoid contact with skin and eyes |
| Packaging Options | 25 kg bags (standard), 25 kg drums, 500-1000 kg FIBCs |
L-Valine should be stored below 25°C in cool, dry, well-ventilated areas, protected from light and moisture. It is slightly hygroscopic and should be protected from moisture. Containers should be kept tightly closed to prevent moisture absorption and contamination. It is incompatible with strong oxidizing agents, strong acids, and strong bases. Shelf life under proper storage conditions is typically 24-36 months.
Handling Notes:
Avoid dust generation (use enclosed systems, local exhaust ventilation)
Avoid contact with skin and eyes (use protective gloves and goggles)
Avoid breathing dust (use dust mask or respirator)
Keep away from ignition sources
Do not allow material to become wet
| Parameter | Information |
|---|---|
| UN Number | Not applicable (not classified as dangerous good) |
| Hazard Class | Not a dangerous good |
| Packing Group | Not applicable |
| Proper Shipping Name | L-Valine |
| Marine Pollutant | No |
| ADR/RID Label | Not applicable |
L-Valine is not classified as a dangerous good for transport. It is shipped in 25 kg bags, drums, or FIBCs. During transport, protect from moisture, impact, and excessive heat.
| Region | Status |
|---|---|
| EU | REACH registered; approved as food and feed additive |
| Turkey (KKDİK) | Mandatory compliance; requires registration |
| USA (TSCA) | Listed; GRAS by FDA |
| Canada (DSL) | Listed |
| Australia (AICS) | Listed |
| Japan (ENCS) | Listed |
| Korea (KECL) | Listed |
| China (IECSC) | Listed |
Regulatory Status:
| Status | Information |
|---|---|
| FDA Compliance | GRAS (Generally Recognized as Safe) |
| EU Compliance | REACH registered; approved as food and feed additive |
| IARC Classification | Not classified |
| HS Code | 29224920 |
| RTECS | YA3993500 |
| WGK Germany | 1 (slight hazard to water) |
| TSCA | Yes |
| EINECS | 200-773-6 |
| Category | Names / Identifiers |
|---|---|
| Chemical Names | (S)-2-Amino-3-methylbutanoic acid |
| Synonyms | L-Valine, Valine, 2-Amino-3-methylbutanoic acid, L-alpha-Amino-beta-methylbutyric acid, L(+)-alpha-Aminoisovaleric Acid |
| Turkish Names | L-Valin, Valin |
| Common Names | "Muscle-building amino acid", "Sports amino acid", "BCAA" |
Database Identifiers:
| Database | Identifier |
|---|---|
| CAS | 72-18-4 |
| EC (EINECS) | 200-773-6 |
| MDL | MFCD00064220 |
| PubChem CID | 6287 |
| RTECS | YA3993500 |
| UN | Not applicable |
| HS Code | 29224920 |
| Merck | 14, 9902 |
| Beilstein | 1721136 |
SUMMARY:
L-Valine (C₅H₁₁NO₂, CAS 72-18-4) is an essential amino acid belonging to the branched-chain amino acid (BCAA) family, along with L-leucine and L-isoleucine. It appears as a white, odorless, crystalline powder with a slightly sweet to bitter taste. The molecular weight is 117.15 g/mol, density is 1.23 g/cm³, melting point is approximately 315°C (sublimes), and water solubility is 88.5 g/L at 25°C. It is produced primarily through fermentation using microorganisms such as Corynebacterium glutamicum or Escherichia coli. L-Valine plays critical roles in protein synthesis, muscle growth and repair, nitrogen balance regulation, and nervous system function. It is widely used in sports nutrition (BCAA supplements, protein powders, pre- and post-workout formulas), dietary supplements, medical applications (liver failure treatment, metabolic disorders, parenteral nutrition), functional foods, and child nutrition. The recommended supplement dose is typically 500-1,500 mg per day (as part of BCAA blends, 2,000-5,000 mg per day). It is considered GRAS (Generally Recognized as Safe) by the FDA, but high doses may cause gastrointestinal distress. It is stored below 25°C in cool, dry, well-ventilated areas, protected from light and moisture. Packaging: 25 kg bags, drums, or FIBCs.
Key Properties:
| Property | Value |
|---|---|
| Appearance | White crystalline powder |
| Chemical Formula | C₅H₁₁NO₂ |
| Molecular Weight | 117.15 g/mol |
| CAS Number | 72-18-4 |
| Melting Point | ~315°C (sublimes) |
| Water Solubility (25°C) | 88.5 g/L |
| Specific Optical Rotation | +27.0 to +29.0° (c=8, 6N HCl) |
| Isoelectric Point | 5.96 |
| Primary Use | Dietary supplement, sports nutrition, pharmaceutical intermediate |
Major Application Areas:
| Industry | Applications |
|---|---|
| Sports Nutrition | BCAA supplements, protein powders, pre/post-workout formulas, endurance products |
| Dietary Supplements | Protein powders, amino acid blends, child growth support products |
| Medical/Pharmaceutical | Liver failure treatment, metabolic disorders, parenteral nutrition |
| Food Industry | Functional foods, protein bars, sports drinks, fortified foods |
| Animal Nutrition | Feed supplement (limited use) |
Key Safety Points:
LOW TOXICITY: GRAS (Generally Recognized as Safe) by FDA
SLIGHTLY HYGROSCOPIC: Protect from moisture; store in tightly closed containers
MILD IRRITANT: May cause mild skin and eye irritation
STORAGE: Store below 25°C in cool, dry, well-ventilated area, protected from light and moisture
PPE REQUIRED: Dust mask, safety goggles, protective gloves (for handling powder)
SIDE EFFECTS: May cause gastrointestinal distress at high doses
CONTRAINDICATIONS: Maple syrup urine disease (MSUD); severe kidney or liver disease
DRUG INTERACTIONS: May interact with levodopa (L-Dopa) and other Parkinson's medications
CRITICAL WARNINGS:
Essential BCAA: L-Valine is one of the three branched-chain amino acids (BCAAs) along with leucine and isoleucine. It cannot be synthesized by the body and must be obtained through diet or supplementation. BCAAs are unique because they are metabolized primarily in muscle tissue rather than the liver, making them critical for muscle protein synthesis and energy production during exercise.
Muscle Growth and Recovery: L-Valine plays a critical role in muscle protein synthesis and repair. It helps reduce muscle breakdown during exercise, supports nitrogen balance, and accelerates post-exercise recovery. In combination with leucine and isoleucine, L-valine is widely used in sports nutrition for muscle building and performance enhancement.
BCAA Synergy: L-Valine works synergistically with L-leucine and L-isoleucine. Leucine is the primary activator of the mTOR pathway (which stimulates muscle protein synthesis), while valine and isoleucine support the process. BCAA blends typically contain a 2:1:1 or 3:1:1 ratio of leucine:isoleucine:valine.
Nervous System Support: L-Valine is involved in nervous system function and may help reduce central fatigue during prolonged exercise. It competes with tryptophan for transport across the blood-brain barrier, which may help reduce serotonin production and delay the onset of fatigue.
Maple Syrup Urine Disease (MSUD): L-Valine is strictly contraindicated in patients with maple syrup urine disease (MSUD), a rare genetic disorder characterized by the inability to metabolize branched-chain amino acids. Accumulation of branched-chain amino acids and their toxic byproducts can lead to severe neurological damage and death.
Liver Failure Treatment: L-Valine is used in the treatment of liver failure and hepatic encephalopathy. It helps correct the amino acid imbalance often seen in liver disease and may improve neurological symptoms.
Drug Interactions: L-Valine may interact with levodopa (L-Dopa) by competing for transport across the blood-brain barrier. Patients taking L-Dopa for Parkinson's disease should consult a healthcare professional before taking L-valine supplements.
Natural Food Sources: L-Valine is naturally found in protein-rich foods including meat, poultry, fish, eggs, dairy products, soybeans, and nuts. Plant-based protein sources are often lower in valine, so supplementation may be beneficial for vegans and vegetarians.
Pregnancy and Lactation: L-Valine is generally considered safe during pregnancy and lactation at recommended doses. However, as with all supplements, it is recommended to consult a healthcare professional before use.
Important Disclaimer: This Technical Data Sheet (TDS) is for informational purposes only. The information provided is based on available data and is believed to be accurate. However, the user is solely responsible for determining the suitability of the product for their specific application and for complying with all applicable regulations and safety requirements. For complete safety, handling, storage, and regulatory compliance information, always refer to the official Safety Data Sheet (SDS/MSDS) provided by the manufacturer/supplier. Users are responsible for testing the product in their own processes and applications. All local, national, and international regulations must be followed when working with L-valine. This is NOT a substitute for professional medical advice. Consult a healthcare professional before use, especially if taking medications, pregnant, or nursing.